Related Experiment Video
Updated: Jul 13, 2026

Isolation, Characterization, And High Throughput Extracellular Flux Analysis of Mouse Primary Renal Tubular Epithelial Cells
Published on: June 20, 2018
Familial mediterranean Fever and renal disease
1University of Iowa Hospitals and Clinics, Department of Pediatrics, Division of Medical Genetics, USA.
Abstract:
Familial Mediterranean Fever (FMF) is a genetic disorder frequently diagnosed among the Arabs. It is also prevalent among Jews, Armenians and Turks. The clinical picture consists of febrile and painful attacks such as joint or chest pain that differ in quality across patients and even within the same patient. The gene responsible for FMF, MEFV, has been cloned and mutations were identified within its coding sequence. It encodes a protein that is expected to be a down regulator of inflammation. The major renal involvement in FMF is the occurrence of amyloidosis that primarily affects the kidneys causing proteinuria and ending in death from renal failure. It can be treated by dialysis and renal transplantation, but can be prevented by a daily regimen of colchicine. Other renal manifestations of FMF are discussed.
Insights
Familial Mediterranean Fever (FMF) is a genetic disorder causing painful attacks and kidney amyloidosis. Daily colchicine prevents this severe renal complication, offering a vital treatment for FMF patients.
Area of Science:
- Genetics
- Immunology
- Nephrology
Background:
- Familial Mediterranean Fever (FMF) is a prevalent genetic autoinflammatory disorder.
- FMF is characterized by recurrent febrile and painful episodes, affecting various populations including Arabs, Jews, Armenians, and Turks.
- The primary severe renal complication of FMF is amyloidosis, leading to kidney failure.
Purpose of the Study:
- To discuss the genetic basis of FMF, focusing on the MEFV gene.
- To detail the renal manifestations of FMF, particularly amyloidosis.
- To highlight the preventive and therapeutic strategies for FMF-related renal disease.
Main Methods:
- Review of the genetic and clinical literature on Familial Mediterranean Fever.
- Identification and discussion of MEFV gene mutations.
- Analysis of renal involvement, including amyloidosis and other manifestations.
Main Results:
- The MEFV gene encodes a protein involved in regulating inflammation.
- Amyloidosis is the major renal manifestation, causing proteinuria and potentially fatal renal failure.
- Colchicine is a highly effective daily treatment for preventing renal amyloidosis in FMF.
Conclusions:
- FMF is a significant genetic disorder with serious renal consequences.
- Early diagnosis and consistent colchicine treatment are crucial for preventing FMF-associated amyloidosis and preserving kidney function.
- Understanding the MEFV gene and FMF pathophysiology aids in managing its renal complications.
More Related Videos
Related Concept Videos
Rocky Mountain Spotted Fever
Chronic Kidney Disease II: Clinical Manifestations
Rheumatic Heart Disease I: Introduction
Nephrotic Syndrome II : Assessment and Medical Management
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Malaria
